Public sources indicate Science 37 operates in home health / dct with a focus on virtual trial platform and a global footprint.
Vendor description
Public sources indicate Science 37 operates in home health / dct with a focus on virtual trial platform and a global footprint.
Hybrid or decentralized studies needing patient-facing services
- Patient convenience
- decentralized execution
- visit flexibility
- Not every protocol element can be decentralized
Approved customer reviews
Write a reviewBe the first customer to share verified experience with this vendor.
Review snapshot
Science 37s public employee reputation is clearly weak in this pass. Glassdoor metrics are low,and Reddit discussion repeatedly flags layoffs,instability,and concerns about long-term job security despite the remote/DCT model being attractive on paper. Employees appear much less confident in leadership and stability than in the companys market story.
Remote/DCT concept - some role appeal - Remote - DCT concept
Layoffs - instability - low recommendation - weak confidence in leadership
Negative
Pricing
$
Key facts
| HQ country | Global |
|---|---|
| Geography | Global |
| Service model | Home health / DCT (decentralized trials) |
| Customer segment | mixed |
| Study phases | Phase I, Phase II, Phase III, Phase IV |
| Trial scale | Focused global studies |
| Therapeutic areas | Generalist |
| Last reviewed | 2026-03-28 |
Related vendors
Editorial ranking
See how Science 37 compares - best Home health / DCT (decentralized trials) vendors for clinical trials.




